Clinical Trial Update: Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies [NA]

View source ↗

Summary

An update on a clinical trial evaluating muscle microRNAs as biomarkers in dystrophinopathies, including Duchenne and Becker muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy
• Duchenne Muscular Dystrophy

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Muscular Dystrophies, Becker Muscular Dystrophy | NA | Status: UNKNOWN